Alger Jason 4

4 · Health Catalyst, Inc. · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 27, 2026

Health Catalyst (HCAT) CFO Jason Alger Receives RSUs, Sells Shares to Cover Taxes

What Happened

Jason Alger, Chief Financial Officer of Health Catalyst (HCAT), received equity awards on Feb 25, 2026: 507,500 restricted stock units (RSUs) and 22,222 performance-based restricted stock units (PRSUs) (total 529,722 units) granted at $0.00. On Feb 26, 2026 he had 7,522 shares sold at $1.75 each to satisfy tax withholding obligations, generating proceeds of $13,147. The grants are awards (code A) and the sale was a tax-withholding disposal (code F).

Key Details

Transaction dates and prices:
- 2026-02-25: Award of 507,500 RSUs (A) and 22,222 PRSUs (A) at $0.00.
- 2026-02-26: 7,522 shares sold/withheld at $1.75 per share (F); proceeds $13,147.
Vesting: RSUs vest in 12 equal quarterly installments beginning March 1, 2026 (per footnote). PRSUs are contingent on fiscal 2025 performance metrics.
Sale reason: The 7,522-share sale was a mandatory "sell to cover" to satisfy tax withholding under the issuer’s equity plan (not a discretionary open-market sale).
Shares owned after transaction: Not disclosed in the Form 4 filing.
Filing timeliness: Form 4 was filed Feb 27, 2026 for transactions on Feb 25–26, 2026 — appears timely (no late filing indicated).

Context

These awards are compensation-based grants (contingent rights to shares), not open-market purchases; they represent potential future share issuance as they vest.
The small sale was solely for tax withholding under the company’s plan and should not be interpreted as a voluntary sell signal from the CFO.
For retail investors, equity awards increase potential future share dilution as they vest; the immediate “sell to cover” was administrative, not an indicator of sentiment.

Form 4

Period: 2026-02-25

Chief Financial Officer

Transactions

Footnotes (3)

[F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026.
[F2]Represents an award of 22,222 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
[F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Signature

/s/Benjamin Landry, as Attorney-in-Fact|2026-02-27

1 file